Recent novel gene discoveries include independent reports of heterozygous loss-of-function variants in kinase insert domain receptor, KDR which is characterised by PAH with low diffusing capacity for carbon monoxide (DLCO) 32, 33, 34. This evidence concerns the gene KDR and pulmonary arterial hypertension.